| 1 |
Long-term safety, efficacy, treatment satisfaction, and impact on healthcare service use of paliperidone palmitate one-month intramuscular formulation in patients with recent-onset schizophrenia in taiwan: A subgroup analysis of an asia-pacific, 18-month, phase 3b study |
|
| | Tze-Chun Tang,Ming-Hong Hsieh,Chen-Chung Liu,Nan-Ying Chiu,Fong-Lin Jang,Chih-Lin Chiang,Tung-Ping Su | | | Taiwanese Journal of Psychiatry. 2019; 33(4): 198 | | | [Pubmed] [Google Scholar] [DOI] | |
|
